Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Curis aggregated by PharmaCompass.com.

    Client Virtual Booth

    CURIS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Curis
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4 Maguire Rd Lexington, MA 02421
    Telephone
    Telephone
    (617) 503-6500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.curis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/curis/
    Twitter
    Twitter
    https://twitter.com/curisinc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study
    Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

    https://www.prnewswire.com/news-releases/curis-announces-initial-combination-study-data-from-its-takeaim-lymphoma-study-302012478.html

    PR NEWSWIRE
    12 Dec 2023
    Share Share
    Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH
    Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH

    https://investors.curis.com/2023-12-11-Curis-Presented-Clinical-Data-from-the-TakeAim-Leukemia-Study-at-the-2023-ASH-Conference

    PRESS RELEASE
    11 Dec 2023
    Share Share
    Curis Announces Three Presentations at ASH
    Curis Announces Three Presentations at ASH

    https://investors.curis.com/2023-12-06-Curis-Announces-Three-Presentations-at-ASH

    PRESS RELEASE
    06 Dec 2023
    Share Share
    Curis Enters into Agreement for Emavusertib Combination Study in Melanoma
    Curis Enters into Agreement for Emavusertib Combination Study in Melanoma

    https://www.prnewswire.com/news-releases/curis-enters-into-agreement-for-emavusertib--pembrolizumab-combination-study-in-melanoma-302005577.html

    PR NEWSWIRE
    05 Dec 2023
    Share Share
    Curis Provides Third Quarter 2023 Business Update
    Curis Provides Third Quarter 2023 Business Update

    https://investors.curis.com/2023-11-02-Curis-Provides-Third-Quarter-2023-Business-Update

    PRESS RELEASE
    02 Nov 2023
    Share Share
    FDA lifts partial hold on Curis' PhI/II leukemia study as biotech raises $15M 
    FDA lifts partial hold on Curis' PhI/II leukemia study as biotech raises $15M 

    https://endpts.com/fda-lifts-partial-hold-on-curis-phi-ii-leukemia-study-as-biotech-raises-15m/

    Paul Schloesser ENDPTS
    07 Jul 2023
    Share Share
    Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/curis-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301791277.html

    PR NEWSWIRE
    05 Apr 2023
    Share Share
    FDA puts Curis' leukemia trial on partial hold after patient death
    FDA puts Curis' leukemia trial on partial hold after patient death

    https://www.fiercebiotech.com/biotech/fda-puts-curis-leukemia-trial-partial-hold-after-patient-death-spurs-review-muscle

    Nick Paul Taylor FIERCE BIOTECH
    04 Apr 2023
    Share Share
    Curis Provides Fourth Quarter 2022 Business Update
    Curis Provides Fourth Quarter 2022 Business Update

    https://www.prnewswire.com/news-releases/curis-provides-fourth-quarter-2022-business-update-301769816.html

    PR NEWSWIRE
    13 Mar 2023
    Share Share
    Curis shrinks headcount by 30% as execs place bigger hopes on blood cancer drug
    Curis shrinks headcount by 30% as execs place bigger hopes on blood cancer drug

    https://endpts.com/curis-shrinks-headcount-by-30-as-execs-place-bigger-hopes-on-blood-cancer-drug/

    Amber Tong ENDPTS
    11 Nov 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search